A study of patients taking medication to control blood pressure has found that those whose readings vary significantly could be at greater risk of heart attack and stroke than those with high blood pressure readings and low variability.
An article published by the European Heart Journal details Imperial College London (ICL) analysis of data from a 20-year study of more than 8,000 UK patients with hypertension.
Related Article: Aggressive hypertension targeting lowers dementia risk, finds large study
The article noted that clinical practice, based on current guidelines, dictates that treatment decisions in patients with hypertension are determined by levels of systolic and diastolic blood pressure – the higher and lower numbers of blood pressure readings respectively.
‘Our studies, however, provide robust evidence that visit-to-visit blood pressure variability is a far more powerful determinant of cardiovascular outcome and that at least half of all cardiovascular events in our cohort occurred in those with controlled blood pressure but high blood pressure variability,’ the article added.
Related Article: First UKHSA report on health inequalities highlights 'stark' impact of deprivation
As a result, the researchers have called for medical guidelines to be changed to take into account interventions where a patient’s blood pressure varies between readings.
The ICL team also highlighted that the drug amlodipine proved effective in lowering blood pressure variability during trials and could help to reduce risk.
Bryan Williams, chief scientific and medical officer at the British Heart Foundation, said: ‘The study suggests that monitoring blood pressure variability could be a vital addition to routine health checks, helping to spot patients who remain at risk despite appearing to have well-controlled blood pressure.
Related Article: Vaping trends stall following regulation announcement
‘The challenge identified by this study for the future, is how to reduce blood pressure variability and smooth the blood pressure profile, beyond the lowering of blood pressure itself which we know is protective against heart attack and stroke.’
Keep your clinical knowledge up to date with The Pharmacist
Extend your learning and record your learning outcomes
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.